AdaptHealth Corp vs Vanguard Ultra Short Bond ETF — how do they compare? AdaptHealth Corp trades at $5.76 (market cap $753.09M), while Vanguard Ultra Short Bond ETF trades at $49.7. The key difference: Vanguard Ultra Short Bond ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | VUSB | |
|---|---|---|
Market Cap | $753.09M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $13.38 | $50.03 |
52-Week Low | $5.22 | $49.60 |
Enterprise Value | $2.77B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
VUSB trades at $49.695, up 0.07% on the day, with a bearish technical outlook indicated by moving averages and ADX signals. Recent news highlights short-term bond ETF appeal amid potential Fed rate hikes. Financial ratios are unavailable, but the fund maintains consistent dividend distributions, with recent payouts around $0.17-$0.18 per share.
The outlook is cautious due to bearish technicals and interest rate sensitivity. Opportunities lie in short-term bond stability if rates rise, but risks include Fed policy shifts and market volatility. Investors should weigh dividend consistency against broader fixed-income pressures.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →